EMS Utilization Of Electrocardiogram In The Field
Introduction
The ability of advanced cardiovascular life support crews to perform a 12-lead ECG in the prehospital setting has expanded across health care settings worldwide over the past several decades. Several organizations have supported this expansion, including the American College of Cardiology Foundation, American Heart Association Task Force, and the European Society of Cardiology. These organizations have released policies recommending that a 12-lead ECG be performed at the point of first medical contact (FMC) for patients with signs or symptoms consistent with acute ST-elevation myocardial infarction (STEMI).[1][2] A prehospital 12-lead ECG is defined as a 12-lead ECG performed by a paramedic on an advanced cardiac life support unit that is either interpreted in the field or transmitted to a hospital emergency department or coronary care unit for interpretation.
The ultimate goal of the prehospital ECG is to provide an early diagnosis of STEMI and ensure the patient is treated appropriately based on the patient's location and the capabilities of local healthcare facilities. Preferably, patients should be transported to a percutaneous coronary intervention (PCI)-capable center with a goal of FMC-to-device time of 90 min or less. This can mean bypassing closer, non–PCI-capable hospitals. However, if FMC-to-device time cannot be achieved in less than 120 min, the patient will require fibrinolytic therapy, if eligible. AHA and ACCF recommendations leave this decision to the discretion of emergency medical service (EMS) clinicians, who determine whether transport to a PCI-capable hospital can occur promptly or whether the patient should be transported to the nearest hospital for fibrinolytic therapy. Results from studies showed that early fibrinolytic therapy is beneficial in reducing morbidity and mortality in patients with acute STEMI who cannot reach a PCI-capable center. In the United States, this approach is primarily performed at rural, non–PCI-capable facilities. Results from numerous studies from several European countries, including the United Kingdom, showed that field fibrinolytic therapy performed by a trained paramedic, with a clinician reviewing the prehospital ECG or in conjunction with a clinician at a nearby facility, can be safe and significantly decrease reperfusion time in acute STEMI. This approach is not widely adopted in the United States due to a lack of funding and training in rural areas where it would provide the most benefit.[2] Therefore, the prehospital 12-lead ECG is an important tool for triaging a patient with symptoms concerning for acute STEMI and for determining whether to transport the patient to the nearest non–PCI-capable hospital, directly to a PCI-capable hospital, or directly to the nearest cardiac catheterization laboratory (CCL).
Issues of Concern
Register For Free And Read The Full Article
Search engine and full access to all medical articles
10 free questions in your specialty
Free CME/CE Activities
Free daily question in your email
Save favorite articles to your dashboard
Emails offering discounts
Learn more about a Subscription to StatPearls Point-of-Care
Issues of Concern
The main goal of the prehospital ECG is to identify STEMI more quickly, leading to timelier intervention in appropriate candidates. Results from several studies showed that decreased FMC-to-device times were associated with lower morbidity and mortality. An effective way to reduce time to PCI is to activate the cardiac catheterization laboratory from the prehospital setting and bypass the emergency department at qualified facilities. Implementing this strategy is a large undertaking for any health system, requiring an interprofessional effort between the EMS services, emergency department staff, interventional cardiologists, and CCL staff. Some clinicians have expressed reservations about false-positive ECG findings from the field. The concern is that unnecessary use of resources may occur with activating the CCL, along with possible iatrogenic injuries and adverse outcomes associated with the procedure itself.[1][2]
Clinical Significance
Prehospital 12-lead ECGs can significantly reduce the time to definitive treatment for STEMI when performed in patients with symptoms concerning for acute STEMI. Patients with a prehospital ECG may bypass a hospital without PCI capabilities to significantly reduce time to definitive intervention. Results from one study of 344 patients showed that the median door-to-balloon time was 69 min for patients who had an ECG performed in the field, interpreted by paramedics, and were transported directly to a PCI-capable facility. This finding compared with a median door-to-balloon time of 123 min in patients referred from an emergency department clinician at a non–PCI-capable facility. Results from this study also demonstrated that 80% versus 12% of patients met the 90-min door-to-balloon time goal upon arrival at a non–PCI-capable center.[3]
Patients who bypass the emergency department based on prehospital ECG findings have significantly decreased FMC-to-reperfusion time. Results from an American Heart Association study of 12,581 patients with STEMI showed that 10.5% were able to bypass the emergency department based on prehospital ECG findings and go directly to the CCL. These patients had a median FMC-to-definitive treatment time of 68 min versus 88 min. Although the 10.5% emergency department bypass rate would ideally be higher, this study found that the bypass rate varied significantly across health systems depending on their resources, training, and system protocols. Results from the study demonstrated that the emergency department was more likely to be bypassed during the daytime, when staffing and resources were higher in the hospital.[4]
Reduction in Mortality in Patients With STEMI
Results from a study based on Britain’s Myocardial Ischemia National Audit Project documented that 288,990 patients presented to the emergency department between 2005 and 2009 by EMS and were ultimately admitted with a diagnosis of STEMI or non-STEMI. Analysis showed reduced 30-day mortality among patients with a prehospital ECG compared with those without (8.6% versus 11.4%). A 30-day mortality reduction was also seen in patients with non-STEMI who had a prehospital ECG compared with those who did not (5.9% versus 6.5%). Results from multiple studies reproduced findings that decreasing time to reperfusion significantly decreases mortality.[1][2][5]
Concern for increased false-positive CCL activation with prehospital 12-lead ECGs used for diagnosis: False-positive CCL activations have been a controversial topic. A true false-positive rate is difficult to obtain because it varies substantially across health systems and studies, with rates ranging from 9% to more than 50%. Over the past 2 decades, with an emphasis on increased FMC-to-reperfusion time, an overall upward trend appears to have occurred in false-positive activations. Results from one retrospective study in Los Angeles showed a 7.8% higher rate of false-positive activations from the prehospital setting. However, results from another study showed a 5% decrease in false-positive CCL activations when ECG transmission to the PCI-capable facility was successful.[6][7][8]
Results from a study of 485 patients, including 77 false-positive CCL activations, showed 7 patients with transient acute kidney injury without other major complications. Findings also showed that hospital costs were relatively minor in false-activation cases. The largest concern was that cardiac catheterization could delay the diagnosis and treatment of another potentially life-threatening pathology, such as pulmonary embolism or aortic dissection.
Summary
A prehospital ECG is an effective tool for triaging patients with STEMI-like symptoms, enhancing transport to the appropriate facility and, ultimately, reperfusion. Although some studies have shown that a prehospital ECG can cause a brief delay from time on scene to hospital arrival, the prehospital ECG ultimately significantly reduces FMC-to-reperfusion time and is associated with a mortality benefit. Although concerns exist about possible false-positive CCL activations, the overall benefits of ECG use outweigh the issues posed by these activations. This overall benefit has led multiple interprofessional and international organizations to promote prehospital 12-lead ECGs. Health systems should work closely with their emergency departments, CCL teams, interventional cardiologists, and EMS services to implement a program to screen patients with potential acute, STEMI-like symptoms with a prehospital 12-lead ECG.
References
Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]. Kardiologia polska. 2018:76(2):229-313. doi: 10.5603/KP.2018.0041. Epub [PubMed PMID: 29457615]
O'Gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology. 2013 Jan 29:61(4):e78-e140. doi: 10.1016/j.jacc.2012.11.019. Epub 2012 Dec 17 [PubMed PMID: 23256914]
Level 3 (low-level) evidenceLe May MR, So DY, Dionne R, Glover CA, Froeschl MP, Wells GA, Davies RF, Sherrard HL, Maloney J, Marquis JF, O'Brien ER, Trickett J, Poirier P, Ryan SC, Ha A, Joseph PG, Labinaz M. A citywide protocol for primary PCI in ST-segment elevation myocardial infarction. The New England journal of medicine. 2008 Jan 17:358(3):231-40. doi: 10.1056/NEJMoa073102. Epub [PubMed PMID: 18199862]
Bagai A, Jollis JG, Dauerman HL, Peng SA, Rokos IC, Bates ER, French WJ, Granger CB, Roe MT. Emergency department bypass for ST-Segment-elevation myocardial infarction patients identified with a prehospital electrocardiogram: a report from the American Heart Association Mission: Lifeline program. Circulation. 2013 Jul 23:128(4):352-9. doi: 10.1161/CIRCULATIONAHA.113.002339. Epub 2013 Jun 20 [PubMed PMID: 23788525]
Quinn T, Johnsen S, Gale CP, Snooks H, McLean S, Woollard M, Weston C, Myocardial Ischaemia National Audit Project (MINAP) Steering Group. Effects of prehospital 12-lead ECG on processes of care and mortality in acute coronary syndrome: a linked cohort study from the Myocardial Ischaemia National Audit Project. Heart (British Cardiac Society). 2014 Jun:100(12):944-50. doi: 10.1136/heartjnl-2013-304599. Epub 2014 Apr 14 [PubMed PMID: 24732676]
Level 2 (mid-level) evidenceSquire BT, Tamayo-Sarver JH, Rashi P, Koenig W, Niemann JT. Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation. Prehospital emergency care. 2014 Jan-Mar:18(1):1-8. doi: 10.3109/10903127.2013.836263. Epub [PubMed PMID: 24329031]
Level 2 (mid-level) evidenceBosson N, Kaji AH, Niemann JT, Squire B, Eckstein M, French WJ, Rashi P, Tadeo R, Koenig W. The Utility of Prehospital ECG Transmission in a Large EMS System. Prehospital emergency care. 2015:19(4):496-503. doi: 10.3109/10903127.2015.1005260. Epub 2015 Apr 22 [PubMed PMID: 25901583]
Larson DM, Menssen KM, Sharkey SW, Duval S, Schwartz RS, Harris J, Meland JT, Unger BT, Henry TD. "False-positive" cardiac catheterization laboratory activation among patients with suspected ST-segment elevation myocardial infarction. JAMA. 2007 Dec 19:298(23):2754-60. doi: 10.1001/jama.298.23.2754. Epub [PubMed PMID: 18165668]